Masimo Corp (MASI)
161.07
+0.92
(+0.57%)
USD |
NASDAQ |
Nov 15, 16:00
162.00
+0.93
(+0.58%)
After-Hours: 20:00
Masimo Research and Development Expense (TTM): 183.10M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 183.10M |
| June 30, 2024 | 181.30M |
| March 31, 2024 | 172.50M |
| December 31, 2023 | 175.20M |
| September 30, 2023 | 191.50M |
| June 30, 2023 | 198.10M |
| March 31, 2023 | 205.70M |
| December 31, 2022 | 191.30M |
| September 30, 2022 | 170.30M |
| June 30, 2022 | 152.60M |
| March 31, 2022 | 138.70M |
| December 31, 2021 | 137.11M |
| September 30, 2021 | 135.54M |
| June 30, 2021 | 128.99M |
| March 31, 2021 | 125.97M |
| December 31, 2020 | 118.70M |
| September 30, 2020 | 110.39M |
| June 30, 2020 | 105.82M |
| March 31, 2020 | 99.12M |
| December 31, 2019 | 93.30M |
| September 30, 2019 | 90.66M |
| June 30, 2019 | 86.95M |
| March 31, 2019 | 82.86M |
| December 31, 2018 | 81.01M |
| September 30, 2018 | 79.59M |
| Date | Value |
|---|---|
| June 30, 2018 | 74.32M |
| March 31, 2018 | 70.62M |
| December 31, 2017 | 65.23M |
| September 30, 2017 | 58.69M |
| June 30, 2017 | 59.06M |
| March 31, 2017 | 57.50M |
| December 31, 2016 | 57.69M |
| September 30, 2016 | 58.66M |
| June 30, 2016 | 57.48M |
| March 31, 2016 | 56.05M |
| December 31, 2015 | 56.62M |
| September 30, 2015 | 57.84M |
| June 30, 2015 | 57.56M |
| March 31, 2015 | 57.51M |
| December 31, 2014 | 56.58M |
| September 30, 2014 | 55.49M |
| June 30, 2014 | 54.92M |
| March 31, 2014 | 55.46M |
| December 31, 2013 | 55.63M |
| September 30, 2013 | 55.03M |
| June 30, 2013 | 53.51M |
| March 31, 2013 | 50.74M |
| December 31, 2012 | 47.08M |
| September 30, 2012 | 43.36M |
| June 30, 2012 | 40.61M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
93.30M
Minimum
Dec 2019
205.70M
Maximum
Mar 2023
150.76M
Average
145.65M
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.519B |
| Baxter International Inc | 754.00M |
| Intuitive Surgical Inc | 1.111B |
| Tandem Diabetes Care Inc | 189.28M |
| Glaukos Corp | 136.96M |